drugset / Trial / NCT02642380

Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)

NCT02642380 ↗

Phase 4 Withdrawn Shandong University
RandomizedParallel-groupOpen-labelTreatment

Summary

The project was organized by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of different cycles of high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Timeline

Start
2015-11
Primary completion
2018-11
Completion
2018-11

Outcome

Outcome not reported

Stopped (Enrollment): “No eligible patient was enrolled.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 40 mg Oral